Univercells Technologies launched the scale-Xâ„¢ nitro controller, expanding its scale-X fixed-bed bioreactor portfolio for viral and advanced therapy manufacturing. Designed to operate 200 m² and 600 ...
Calgary, Alberta--(Newsfile Corp. - February 20, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is delighted to announce a strategic breakthrough that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results